Thor Medical ASA (TRMED) — Cash Flow-to-Debt Ratio
Thor Medical ASA (TRMED) has a Cash Flow-to-Debt Ratio of 0.00x as of December 2024, meaning its operating cash flow of Nkr-5.74K could theoretically repay 0% of its total liabilities (Nkr77.30 Million) in one year. See TRMED working capital ratio to evaluate short-term liquidity relative to the company's equity base.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Thor Medical ASA Cash Flow-to-Debt Ratio (2019–2024)
Historical debt coverage capacity for Thor Medical ASA across 6 annual periods. Also explore TRMED net asset momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Thor Medical ASA (2019–2024)
Year-by-year debt coverage analysis for Thor Medical ASA. For market capitalisation and broader financial context, see Thor Medical ASA (TRMED) market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (NOK) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -0.31x | Nkr-23.70 Million | Nkr77.30 Million | ▲ +71.8% |
| 2023 | -1.09x | Nkr-64.09 Million | Nkr58.91 Million | ▲ +87.8% |
| 2022 | -8.93x | Nkr-409.08 Million | Nkr45.80 Million | ▼ -245.7% |
| 2021 | -2.58x | Nkr-403.46 Million | Nkr156.16 Million | ▲ +11.8% |
| 2020 | -2.93x | Nkr-398.21 Million | Nkr135.94 Million | ▲ +96.7% |
| 2019 | -89.83x | Nkr-410.62 Million | Nkr4.57 Million | — |